[The importance of 111-indium marked leukocyte scintigraphy in inflammatory intracranial processes]

M Lange1, L Ziegler, C Hamburger

  • 1Neurochirurgische Klinik der Ludwig-Maximilians-Universität München.

Neurochirurgia
|September 1, 1989
PubMed

Insights

111-indium-labelled leukocyte scintigraphy is an 80% reliable method for diagnosing intracranial lesions but suffers from delays and supply issues. This limits its utility for neurosurgeons needing timely operational guidance.

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Inflammatory intracranial lesions require precise delimitation for effective neurosurgical intervention.
  • 111-indium-labelled leukocyte scintigraphy is a diagnostic tool used in this context.

Observation:

  • The method demonstrates reliable results in 80% of cases.
  • However, 10% of cases yield false-positive or false-negative outcomes.
  • Significant time loss occurs due to a 24-hour waiting period and supply chain challenges.

Findings:

  • The diagnostic accuracy is limited by false results.
  • Operational delays are inherent due to the lengthy procedure and logistical issues.
  • The current method provides insufficient timely information for surgical decision-making.

Implications:

  • There is a critical need to enhance the existing scintigraphy technique.
  • Development of novel diagnostic approaches for inflammatory intracranial lesions is warranted.
  • Improved diagnostic tools are essential for optimizing neurosurgical timing and patient outcomes.

Related Concept Videos